- Home
- KRON vs NMS Comparison
KRON vs NMS Comparison
Compare KRON & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- NMS
- Stock Information
- Founded
- KRON 2017
- NMS 1993
- Country
- KRON United States
- NMS United States
- Employees
- KRON N/A
- NMS N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- NMS Finance Companies
- Sector
- KRON Health Care
- NMS Finance
- Exchange
- KRON Nasdaq
- NMS Nasdaq
- Market Cap
- KRON 61.5M
- NMS 71.8M
- IPO Year
- KRON 2020
- NMS N/A
- Fundamental
- Price
- KRON $0.83
- NMS $12.01
- Analyst Decision
- KRON Buy
- NMS
- Analyst Count
- KRON 3
- NMS 0
- Target Price
- KRON $1.63
- NMS N/A
- AVG Volume (30 Days)
- KRON 165.9K
- NMS 12.0K
- Earning Date
- KRON 03-18-2025
- NMS 01-01-0001
- Dividend Yield
- KRON N/A
- NMS 4.11%
- EPS Growth
- KRON N/A
- NMS N/A
- EPS
- KRON N/A
- NMS N/A
- Revenue
- KRON $9,848,000.00
- NMS N/A
- Revenue This Year
- KRON N/A
- NMS N/A
- Revenue Next Year
- KRON N/A
- NMS N/A
- P/E Ratio
- KRON N/A
- NMS N/A
- Revenue Growth
- KRON 56.62
- NMS N/A
- 52 Week Low
- KRON $0.69
- NMS $9.21
- 52 Week High
- KRON $1.60
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- KRON 27.47
- NMS 25.70
- Support Level
- KRON $0.82
- NMS $12.09
- Resistance Level
- KRON $0.95
- NMS $12.27
- Average True Range (ATR)
- KRON 0.06
- NMS 0.08
- MACD
- KRON -0.01
- NMS -0.02
- Stochastic Oscillator
- KRON 3.12
- NMS 12.33
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.